News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
89 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28549)
Month
January (2434)
February (2869)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (3178)
November (247)
Day
1 (167)
2 (22)
3 (10)
4 (48)
5 (185)
6 (145)
7 (156)
8 (155)
9 (41)
12 (152)
13 (137)
14 (135)
15 (192)
16 (43)
18 (37)
19 (172)
20 (163)
21 (127)
22 (143)
23 (101)
25 (36)
26 (231)
27 (174)
28 (122)
29 (195)
30 (89)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
2
3
4
5
6
7
8
9
12
13
14
15
16
18
19
20
21
22
23
25
26
27
28
29
30
Opinion
Once undruggable, the Wnt/B-catenin pathway shows increasing promise
Early-stage clinical data from our company and others point to the Wnt/β-catenin pathway as a new avenue for targeting multiple cancer types.
October 30, 2026
·
5 min read
·
Rahul Aras
Press Releases
Edison Scientific Announces Agreement with Pfizer to Accelerate Research and Development
October 30, 2026
·
1 min read
Press Releases
OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
October 30, 2026
·
8 min read
Venture capital
New biotech Setara forms with $90M to take on Jazz’s bonus rare disease programs
Setara Biosciences has formed around a handful of assets from Actio Biosciences, which was acquired by Jazz Pharmaceuticals earlier this year.
October 30, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Pro-Dex, Inc. Announces Fiscal 2027 First Quarter Results
October 30, 2026
·
6 min read
Press Releases
Supernus Announces Third Quarter 2026 Financial Results
October 30, 2026
·
22 min read
Press Releases
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
October 30, 2026
·
24 min read
Press Releases
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
October 30, 2026
·
2 min read
Press Releases
Stryker reports third quarter 2026 operating results
October 30, 2026
·
26 min read
Press Releases
Immuneering Reports Third Quarter 2026 Financial Results and Provides Business Updates
October 30, 2026
·
12 min read
1 of 9
Next
